牛磺酸颗粒联合地塞米松在输血前预防性应用对输血过敏反应的影响分析  

An analysis of efficacy of the Niuhuangsuan capsules plus Dexamethasone on transfusion allergies before transfusion

作　　者：王光乾 姜彩红 

机构地区：[1]枣庄市中心血站,山东枣庄277000 [2]枣庄市市中区人民医院,山东枣庄277000

出　　处：《中医临床研究》2015年第29期103-104,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探究牛磺酸颗粒联合地塞米松在输血前预防性应用对输血过敏反应的影响。方法:对本院消化和肾内科的300例输血病例输血563次,根据输血前预防性用药分为两组。输血前给予口服牛磺颗粒联合静脉滴注地塞米松为观察组,输血前单纯给予静脉滴注地塞米松为对照组。收集整理数据,运用SPSS18.0进行统计分析,比较两组过敏反应发生率的差异。结果:观察组283次输血中,过敏反应率为1.41%,对照组280例中输血过敏反应率为1.77%,两组差异无统计学意义。结论:输血前预防性地给予牛磺酸颗粒联合地塞米松并不能有效降低输血过程中过敏反应的发生率。Objective： To explore effects of the Niuhuangsuan capsules and Dexamethasone on transfusion allergies before transfusion. Methods： 300 cases received 563 transfusions and were divided into two groups according to preventive medication before transfusion. Before transfusion, the control group received Dexamethasone. The observed group received the Niuhuangsuan capsules more. Results： In the observation group, the efficiency of anaphylaxis was 1.41%. In the other group the efficiency of anaphylaxis was 1.77%, without statistically significant difference. Conclusion： Before transfusion of blood, applying the Niuhuangsuan capsules and Dexamethasone cannot reduce the incidence of allergies.

关 键 词：牛磺酸颗粒 地塞米松 过敏反应 

分 类 号：R457.13[医药卫生—治疗学]